Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
129,668,560
-
Number of holders
-
256
-
Total 13F shares, excl. options
-
93,293,806
-
Shares change
-
+1,209,931
-
Total reported value, excl. options
-
$2,729,193,664
-
Value change
-
+$45,246,831
-
Put/Call ratio
-
102%
-
Number of buys
-
125
-
Number of sells
-
-115
-
Price
-
$29.25
Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q4 2019
304 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q4 2019.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 256 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93,293,806 shares
of 129,668,560 outstanding shares and own 72% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15,589,132 shares), VANGUARD GROUP INC (10,513,003 shares), Kopp Family Office, LLC (4,844,625 shares), JANUS HENDERSON GROUP PLC (3,472,040 shares), Artisan Partners Limited Partnership (2,932,090 shares), STATE STREET CORP (2,770,947 shares), BROWN ADVISORY INC (2,677,664 shares), EAGLE ASSET MANAGEMENT INC (2,487,103 shares), Invesco Ltd. (2,295,873 shares), and Granite Investment Partners, LLC (1,920,723 shares).
This table shows the top 256 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.